Diseases, Conditions, Syndromes

Adding tirzepatide to insulin glargine ups glycemic control in T2DM

(HealthDay)—The addition of subcutaneous tirzepatide versus placebo to titrated insulin glargine results in significant improvements in glycemic control among patients with type 2 diabetes and inadequate glycemic control, ...

page 6 from 18